Deutsche Bank Ag\ Chembio Diagnostics, Inc. Transaction History

Deutsche Bank Ag\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$2.06 - $5.34 $70,040 - $181,560	-34,000 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$2.88 - $5.64 $61,355 - $120,154	21,304 Added 167.8%	34,000 $101,000
Q1 2021 May 13, 2021	SELL	$3.4 - $7.97 $4,144 - $9,715	-1,219 Reduced 8.76%	12,696 $44,000
Q4 2020 Feb 16, 2021	SELL	$4.11 - $7.51 $1,611 - $2,943	-392 Reduced 2.74%	13,915 $66,000
Q3 2020 Nov 12, 2020	BUY	$3.28 - $5.93 $17,508 - $31,654	5,338 Added 59.52%	14,307 $69,000
Q2 2020 Aug 13, 2020	BUY	$3.18 - $15.54 $28,521 - $139,378	8,969 New	8,969 $29,000
Q3 2019 Nov 14, 2019	SELL	$4.84 - $7.25 $163,243 - $244,528	-33,728 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$5.56 - $7.85 $203,340 - $287,090	-36,572 Reduced 52.02%	33,728 $205,000
Q1 2019 May 15, 2019	SELL	$5.32 - $7.18 $67,218 - $90,719	-12,635 Reduced 15.23%	70,300 $390,000
Q4 2018 Feb 14, 2019	BUY	$4.95 - $10.5 $213,745 - $453,400	43,181 Added 108.62%	82,935 $469,000
Q3 2018 Nov 14, 2018	BUY	$9.2 - $11.5 $182,426 - $228,033	19,829 Added 99.52%	39,754 $417,000
Q2 2018 Aug 14, 2018	BUY	$7.8 - $11.1 $155,415 - $221,167	19,925 New	19,925 $220,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.